MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Cognitive function and self-reported depressive symptoms in a population-based cohort to study non-motor-symptoms of Parkinson’s disease

E.J. Vollstedt, K. Hückelheim, S. Tunc, J. Hampf, C. Kritzinger, M. Kasten, C. Klein (Luebeck, Germany)

Meeting: 2016 International Congress

Abstract Number: 1471

Keywords: Cognitive dysfunction, Depression, Parkinsonism

Session Information

Date: Wednesday, June 22, 2016

Session Title: Parkinson's disease: Psychiatric manifestations

Session Time: 12:00pm-1:30pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To describe the relation of depressive symptoms with cognitive performance in our cohort at baseline and two-year follow-up.

Background: Cognitive function (CF) is frequent in the course of Parkinson’s disease (PD) and contributes to a reduced quality of life and independency. Similarly, in the general elderly population CF is an important parameter for independency. The clinical evaluation of CF can be hampered e.g. by the parallel presence of depressive symptoms.

Methods: Based on a population screening we examined 759 subjects (141 PD patients). As screening tools we performed the Montreal Cognitive Assessment (MoCA) for CF and the Beck Depression Inventory (BDI) for depressive symptoms. We applied Pearson’s correlation for comparison.

Results: The mean MoCA score in our cohort was 24.7±3.6 (PD 22.7±4.3) at baseline and 25.8±3.3 (PD 24.2±4.4) after two years. The mean BDI score was 9.5±8.0 (PD 9.8±7.5) at baseline and 8.1±7.0 (PD 11.2±9.1) at follow-up. MoCA and BDI correlated only in PD patients (r=-.040, p=.192, PD r=-.243, p=.013) at baseline, but not (r=-.033, p=.301, PD r=-.114, p=.337) at follow-up. Changes in both scores after two years did not correlate (r=.024, p=.358; PD r=-0.090, p=.379).

Conclusions: In our cohort, the MoCA scores seem to be largely unaffected by depressive symptoms reported in the BDI. This finding is contradictory to clinical observations and may be explained by the predominantly mild depressive symptoms in our cohort and the outpatient setting. Follow-up examinations in participants with more severe depressive symptoms will help to test this hypothesis.

To cite this abstract in AMA style:

E.J. Vollstedt, K. Hückelheim, S. Tunc, J. Hampf, C. Kritzinger, M. Kasten, C. Klein. Cognitive function and self-reported depressive symptoms in a population-based cohort to study non-motor-symptoms of Parkinson’s disease [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/cognitive-function-and-self-reported-depressive-symptoms-in-a-population-based-cohort-to-study-non-motor-symptoms-of-parkinsons-disease/. Accessed May 13, 2025.
  • Tweet
  • Email
  • Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/cognitive-function-and-self-reported-depressive-symptoms-in-a-population-based-cohort-to-study-non-motor-symptoms-of-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • #23624 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley